nodes	percent_of_prediction	percent_of_DWPC	metapath
Torasemide—PTGS1—malignant glioma	0.906	1	CbGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—POR—malignant glioma	0.0013	0.0166	CbGpPWpGaD
Torasemide—CYP2C8—Xenobiotics—CYP2B6—malignant glioma	0.00123	0.0158	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00118	0.0151	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00113	0.0145	CbGpPWpGaD
Torasemide—CYP2C19—Xenobiotics—CYP2B6—malignant glioma	0.0011	0.0141	CbGpPWpGaD
Torasemide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—malignant glioma	0.00108	0.0138	CbGpPWpGaD
Torasemide—CYP2C8—Xenobiotics—CYP2C18—malignant glioma	0.00107	0.0137	CbGpPWpGaD
Torasemide—SLC12A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00103	0.0131	CbGpPWpGaD
Torasemide—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.001	0.0129	CbGpPWpGaD
Torasemide—CYP2C19—Xenobiotics—CYP2C18—malignant glioma	0.000956	0.0122	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—PTK2—malignant glioma	0.000911	0.0117	CbGpPWpGaD
Torasemide—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.000871	0.0111	CbGpPWpGaD
Torasemide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000757	0.00968	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—FN1—malignant glioma	0.00069	0.00883	CbGpPWpGaD
Torasemide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00069	0.00883	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00067	0.00858	CbGpPWpGaD
Torasemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000657	0.00841	CbGpPWpGaD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000643	0.00823	CbGpPWpGaD
Torasemide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—malignant glioma	0.00064	0.00819	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000613	0.00784	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—PIK3CD—malignant glioma	0.000581	0.00743	CbGpPWpGaD
Torasemide—Thirst—Temozolomide—malignant glioma	0.000569	0.0359	CcSEcCtD
Torasemide—Hyponatraemia—Carmustine—malignant glioma	0.000563	0.0355	CcSEcCtD
Torasemide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00056	0.0353	CcSEcCtD
Torasemide—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000558	0.00714	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000536	0.00686	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—BCL2—malignant glioma	0.000528	0.00676	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000521	0.00667	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000513	0.00656	CbGpPWpGaD
Torasemide—Hypokalaemia—Carmustine—malignant glioma	0.00051	0.0322	CcSEcCtD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000506	0.00647	CbGpPWpGaD
Torasemide—Dehydration—Temozolomide—malignant glioma	0.000504	0.0318	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—PTGS2—malignant glioma	0.000501	0.00642	CbGpPWpGaD
Torasemide—Hypokalaemia—Temozolomide—malignant glioma	0.000493	0.0311	CcSEcCtD
Torasemide—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000488	0.0308	CcSEcCtD
Torasemide—PTGS1—Overview of nanoparticle effects—CXCL8—malignant glioma	0.000486	0.00622	CbGpPWpGaD
Torasemide—SLC12A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000482	0.00617	CbGpPWpGaD
Torasemide—SLC12A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000459	0.00587	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000458	0.00586	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000452	0.00578	CbGpPWpGaD
Torasemide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000445	0.00569	CbGpPWpGaD
Torasemide—CYP2C8—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000439	0.00561	CbGpPWpGaD
Torasemide—Hyperglycaemia—Carmustine—malignant glioma	0.000437	0.0276	CcSEcCtD
Torasemide—Erectile dysfunction—Temozolomide—malignant glioma	0.000431	0.0272	CcSEcCtD
Torasemide—Hyperglycaemia—Temozolomide—malignant glioma	0.000422	0.0266	CcSEcCtD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000417	0.00534	CbGpPWpGaD
Torasemide—PTGS1—Eicosanoid Synthesis—PTGS2—malignant glioma	0.000416	0.00532	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000416	0.00532	CbGpPWpGaD
Torasemide—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000414	0.0261	CcSEcCtD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000412	0.00527	CbGpPWpGaD
Torasemide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000397	0.00508	CbGpPWpGaD
Torasemide—CYP2C19—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000392	0.00501	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00039	0.00499	CbGpPWpGaD
Torasemide—Haemoglobin—Carmustine—malignant glioma	0.00039	0.0246	CcSEcCtD
Torasemide—Haemorrhage—Carmustine—malignant glioma	0.000388	0.0244	CcSEcCtD
Torasemide—Haemoglobin—Temozolomide—malignant glioma	0.000376	0.0237	CcSEcCtD
Torasemide—Haemorrhage—Temozolomide—malignant glioma	0.000375	0.0236	CcSEcCtD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000371	0.00475	CbGpPWpGaD
Torasemide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000362	0.00463	CbGpPWpGaD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00036	0.00461	CbGpPWpGaD
Torasemide—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000357	0.00457	CbGpPWpGaD
Torasemide—Erythema multiforme—Temozolomide—malignant glioma	0.000354	0.0223	CcSEcCtD
Torasemide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—malignant glioma	0.000348	0.00445	CbGpPWpGaD
Torasemide—CYP2C19—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000348	0.00445	CbGpPWpGaD
Torasemide—PTGS1—Biological oxidations—CYP2B6—malignant glioma	0.000342	0.00437	CbGpPWpGaD
Torasemide—PTGS1—Overview of nanoparticle effects—TNF—malignant glioma	0.000339	0.00433	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000338	0.00433	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000322	0.00412	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000317	0.00406	CbGpPWpGaD
Torasemide—Leukopenia—Carmustine—malignant glioma	0.000302	0.019	CcSEcCtD
Torasemide—Angioedema—Temozolomide—malignant glioma	0.000298	0.0188	CcSEcCtD
Torasemide—PTGS1—Biological oxidations—CYP2C18—malignant glioma	0.000296	0.00379	CbGpPWpGaD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000293	0.00375	CbGpPWpGaD
Torasemide—Leukopenia—Temozolomide—malignant glioma	0.000292	0.0184	CcSEcCtD
Torasemide—PTGS1—Selenium Micronutrient Network—SOD1—malignant glioma	0.000291	0.00372	CbGpPWpGaD
Torasemide—Myalgia—Carmustine—malignant glioma	0.000287	0.0181	CcSEcCtD
Torasemide—Chest pain—Carmustine—malignant glioma	0.000287	0.0181	CcSEcCtD
Torasemide—Cough—Temozolomide—malignant glioma	0.000285	0.0179	CcSEcCtD
Torasemide—Myalgia—Temozolomide—malignant glioma	0.000278	0.0175	CcSEcCtD
Torasemide—Arthralgia—Temozolomide—malignant glioma	0.000278	0.0175	CcSEcCtD
Torasemide—PTGS1—Selenium Micronutrient Network—CAT—malignant glioma	0.000276	0.00354	CbGpPWpGaD
Torasemide—Oedema—Carmustine—malignant glioma	0.000275	0.0174	CcSEcCtD
Torasemide—CYP2C8—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000273	0.00349	CbGpPWpGaD
Torasemide—Thrombocytopenia—Carmustine—malignant glioma	0.00027	0.017	CcSEcCtD
Torasemide—SLC12A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000267	0.00341	CbGpPWpGaD
Torasemide—Oedema—Temozolomide—malignant glioma	0.000266	0.0168	CcSEcCtD
Torasemide—Thrombocytopenia—Temozolomide—malignant glioma	0.000261	0.0164	CcSEcCtD
Torasemide—Hypotension—Carmustine—malignant glioma	0.000257	0.0162	CcSEcCtD
Torasemide—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000251	0.0158	CcSEcCtD
Torasemide—Insomnia—Carmustine—malignant glioma	0.000249	0.0157	CcSEcCtD
Torasemide—SLC12A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000245	0.00314	CbGpPWpGaD
Torasemide—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000244	0.00312	CbGpPWpGaD
Torasemide—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000242	0.0153	CcSEcCtD
Torasemide—Insomnia—Temozolomide—malignant glioma	0.000241	0.0152	CcSEcCtD
Torasemide—PTGS1—Biological oxidations—GSTT1—malignant glioma	0.00024	0.00307	CbGpPWpGaD
Torasemide—Constipation—Carmustine—malignant glioma	0.000235	0.0149	CcSEcCtD
Torasemide—Pain—Carmustine—malignant glioma	0.000235	0.0149	CcSEcCtD
Torasemide—Dyspepsia—Temozolomide—malignant glioma	0.000234	0.0148	CcSEcCtD
Torasemide—SLC12A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000233	0.00298	CbGpPWpGaD
Torasemide—PTGS1—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000231	0.00296	CbGpPWpGaD
Torasemide—Pain—Temozolomide—malignant glioma	0.000228	0.0144	CcSEcCtD
Torasemide—Constipation—Temozolomide—malignant glioma	0.000228	0.0144	CcSEcCtD
Torasemide—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000222	0.00284	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP2B6—malignant glioma	0.000221	0.00283	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—CYP2B6—malignant glioma	0.000218	0.00279	CbGpPWpGaD
Torasemide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00021	0.00269	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—F2—malignant glioma	0.000202	0.00259	CbGpPWpGaD
Torasemide—Asthenia—Carmustine—malignant glioma	0.000198	0.0125	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—CYP2B6—malignant glioma	0.000197	0.00252	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—CYP2B6—malignant glioma	0.000194	0.00249	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—CYP2C18—malignant glioma	0.000191	0.00245	CbGpPWpGaD
Torasemide—Asthenia—Temozolomide—malignant glioma	0.000191	0.012	CcSEcCtD
Torasemide—CYP2C8—Metapathway biotransformation—CYP2C18—malignant glioma	0.000189	0.00242	CbGpPWpGaD
Torasemide—Diarrhoea—Carmustine—malignant glioma	0.000188	0.0119	CcSEcCtD
Torasemide—Dizziness—Carmustine—malignant glioma	0.000182	0.0115	CcSEcCtD
Torasemide—Diarrhoea—Temozolomide—malignant glioma	0.000182	0.0115	CcSEcCtD
Torasemide—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.00018	0.0023	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.000177	0.00227	CbGpPWpGaD
Torasemide—Dizziness—Temozolomide—malignant glioma	0.000176	0.0111	CcSEcCtD
Torasemide—Vomiting—Carmustine—malignant glioma	0.000175	0.011	CcSEcCtD
Torasemide—Rash—Carmustine—malignant glioma	0.000174	0.011	CcSEcCtD
Torasemide—Dermatitis—Carmustine—malignant glioma	0.000173	0.0109	CcSEcCtD
Torasemide—Headache—Carmustine—malignant glioma	0.000173	0.0109	CcSEcCtD
Torasemide—CYP2C19—Biological oxidations—CYP2C18—malignant glioma	0.000171	0.00219	CbGpPWpGaD
Torasemide—Vomiting—Temozolomide—malignant glioma	0.000169	0.0107	CcSEcCtD
Torasemide—CYP2C19—Metapathway biotransformation—CYP2C18—malignant glioma	0.000169	0.00216	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—RTEL1—malignant glioma	0.000168	0.00215	CbGpPWpGaD
Torasemide—Rash—Temozolomide—malignant glioma	0.000168	0.0106	CcSEcCtD
Torasemide—Dermatitis—Temozolomide—malignant glioma	0.000168	0.0106	CcSEcCtD
Torasemide—Headache—Temozolomide—malignant glioma	0.000167	0.0105	CcSEcCtD
Torasemide—PTGS1—Biological oxidations—GSTP1—malignant glioma	0.000166	0.00213	CbGpPWpGaD
Torasemide—Nausea—Carmustine—malignant glioma	0.000164	0.0103	CcSEcCtD
Torasemide—Nausea—Temozolomide—malignant glioma	0.000158	0.00997	CcSEcCtD
Torasemide—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.000156	0.00199	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTT1—malignant glioma	0.000155	0.00198	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000154	0.00197	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—IFNG—malignant glioma	0.000153	0.00196	CbGpPWpGaD
Torasemide—CYP2C8—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000149	0.00191	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—PTGS2—malignant glioma	0.000147	0.00188	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—PTGS1—malignant glioma	0.000145	0.00186	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTT1—malignant glioma	0.000138	0.00177	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	0.000137	0.00175	CbGpPWpGaD
Torasemide—CYP2C19—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000133	0.00171	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—PTGS1—malignant glioma	0.000129	0.00166	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000126	0.00161	CbGpPWpGaD
Torasemide—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000122	0.00156	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00012	0.00154	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.000118	0.00151	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000116	0.00149	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—RTEL1—malignant glioma	0.000109	0.00139	CbGpPWpGaD
Torasemide—CYP2C8—Biological oxidations—GSTP1—malignant glioma	0.000107	0.00137	CbGpPWpGaD
Torasemide—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	0.000106	0.00135	CbGpPWpGaD
Torasemide—SLC12A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000106	0.00135	CbGpPWpGaD
Torasemide—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	9.93e-05	0.00127	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—RTEL1—malignant glioma	9.69e-05	0.00124	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—COX8A—malignant glioma	9.65e-05	0.00123	CbGpPWpGaD
Torasemide—CYP2C19—Biological oxidations—GSTP1—malignant glioma	9.58e-05	0.00123	CbGpPWpGaD
Torasemide—CYP2C19—Metapathway biotransformation—GSTP1—malignant glioma	9.45e-05	0.00121	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—RTEL1—malignant glioma	8.83e-05	0.00113	CbGpPWpGaD
Torasemide—CYP2C9—Biological oxidations—GSTP1—malignant glioma	8.73e-05	0.00112	CbGpPWpGaD
Torasemide—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	8.61e-05	0.0011	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—ASMT—malignant glioma	8.2e-05	0.00105	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	8.02e-05	0.00103	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.75e-05	0.000992	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—BCAN—malignant glioma	7.71e-05	0.000987	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.5e-05	0.00096	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.92e-05	0.000886	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.7e-05	0.000857	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	6.31e-05	0.000808	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—COX8A—malignant glioma	6.23e-05	0.000797	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—IDH2—malignant glioma	6.22e-05	0.000796	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	6.11e-05	0.000781	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	5.86e-05	0.00075	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2B6—malignant glioma	5.85e-05	0.000748	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	5.57e-05	0.000713	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—COX8A—malignant glioma	5.56e-05	0.000712	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—IDH1—malignant glioma	5.35e-05	0.000684	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—ASMT—malignant glioma	5.3e-05	0.000678	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.18e-05	0.000663	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SPHK1—malignant glioma	5.17e-05	0.000662	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—COX8A—malignant glioma	5.07e-05	0.000649	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CYP2C18—malignant glioma	5.07e-05	0.000649	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—BCAN—malignant glioma	4.98e-05	0.000638	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.97e-05	0.000636	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	4.78e-05	0.000612	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—ASMT—malignant glioma	4.73e-05	0.000605	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.62e-05	0.000592	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	4.53e-05	0.00058	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—BCAN—malignant glioma	4.45e-05	0.000569	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	4.35e-05	0.000557	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—ASMT—malignant glioma	4.31e-05	0.000552	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	4.22e-05	0.000539	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	4.2e-05	0.000538	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTT1—malignant glioma	4.1e-05	0.000525	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—BCAN—malignant glioma	4.05e-05	0.000519	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—IDH2—malignant glioma	4.02e-05	0.000514	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	3.83e-05	0.00049	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.79e-05	0.000485	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2B6—malignant glioma	3.78e-05	0.000483	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—IDH2—malignant glioma	3.58e-05	0.000459	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—BCHE—malignant glioma	3.57e-05	0.000457	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—SLC5A5—malignant glioma	3.53e-05	0.000451	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—IDH1—malignant glioma	3.45e-05	0.000442	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.38e-05	0.000433	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2B6—malignant glioma	3.37e-05	0.000431	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SPHK1—malignant glioma	3.34e-05	0.000428	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.34e-05	0.000427	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.31e-05	0.000423	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CYP2C18—malignant glioma	3.27e-05	0.000419	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—IDH2—malignant glioma	3.27e-05	0.000418	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.09e-05	0.000395	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—IDH1—malignant glioma	3.08e-05	0.000394	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.08e-05	0.000394	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2B6—malignant glioma	3.07e-05	0.000393	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SPHK1—malignant glioma	2.98e-05	0.000382	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CYP2C18—malignant glioma	2.92e-05	0.000374	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.88e-05	0.000369	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—GSTP1—malignant glioma	2.84e-05	0.000364	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.81e-05	0.00036	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—IDH1—malignant glioma	2.81e-05	0.00036	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CAT—malignant glioma	2.76e-05	0.000354	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.76e-05	0.000353	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SPHK1—malignant glioma	2.72e-05	0.000348	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.71e-05	0.000347	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CYP2C18—malignant glioma	2.66e-05	0.000341	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTT1—malignant glioma	2.65e-05	0.000339	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—NCOR1—malignant glioma	2.61e-05	0.000334	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.51e-05	0.000321	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.51e-05	0.000321	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS1—malignant glioma	2.48e-05	0.000317	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.47e-05	0.000316	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.42e-05	0.00031	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTT1—malignant glioma	2.36e-05	0.000302	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—BCHE—malignant glioma	2.31e-05	0.000295	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.29e-05	0.000293	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—SLC5A5—malignant glioma	2.28e-05	0.000292	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS1—malignant glioma	2.21e-05	0.000283	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.21e-05	0.000283	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.21e-05	0.000282	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTT1—malignant glioma	2.15e-05	0.000276	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.15e-05	0.000276	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.13e-05	0.000273	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—CAV1—malignant glioma	2.13e-05	0.000272	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—BCHE—malignant glioma	2.06e-05	0.000263	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—SLC5A5—malignant glioma	2.03e-05	0.00026	CbGpPWpGaD
Torasemide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.03e-05	0.00026	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS1—malignant glioma	2.02e-05	0.000258	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.01e-05	0.000257	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CG—malignant glioma	1.94e-05	0.000248	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.92e-05	0.000246	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.91e-05	0.000244	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—BCHE—malignant glioma	1.88e-05	0.00024	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PPARG—malignant glioma	1.87e-05	0.000239	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.86e-05	0.000238	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.85e-05	0.000237	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—GSTP1—malignant glioma	1.84e-05	0.000235	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CAT—malignant glioma	1.79e-05	0.000229	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.75e-05	0.000224	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.74e-05	0.000222	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CD—malignant glioma	1.7e-05	0.000218	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—NCOR1—malignant glioma	1.69e-05	0.000216	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.66e-05	0.000213	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—GSTP1—malignant glioma	1.64e-05	0.00021	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CAT—malignant glioma	1.59e-05	0.000204	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.52e-05	0.000194	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—NCOR1—malignant glioma	1.51e-05	0.000193	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—GSTP1—malignant glioma	1.49e-05	0.000191	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CB—malignant glioma	1.49e-05	0.00019	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTGS2—malignant glioma	1.47e-05	0.000188	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CAT—malignant glioma	1.45e-05	0.000186	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—CAV1—malignant glioma	1.37e-05	0.000176	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—NCOR1—malignant glioma	1.37e-05	0.000176	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.31e-05	0.000168	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PTEN—malignant glioma	1.28e-05	0.000164	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CG—malignant glioma	1.25e-05	0.00016	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—CAV1—malignant glioma	1.23e-05	0.000157	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PPARG—malignant glioma	1.21e-05	0.000155	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.17e-05	0.00015	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—CAV1—malignant glioma	1.12e-05	0.000143	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CG—malignant glioma	1.12e-05	0.000143	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CD—malignant glioma	1.1e-05	0.000141	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PPARG—malignant glioma	1.08e-05	0.000138	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.07e-05	0.000137	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CG—malignant glioma	1.02e-05	0.00013	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PPARG—malignant glioma	9.84e-06	0.000126	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CD—malignant glioma	9.83e-06	0.000126	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CB—malignant glioma	9.6e-06	0.000123	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTGS2—malignant glioma	9.51e-06	0.000122	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—PIK3CA—malignant glioma	9.06e-06	0.000116	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CD—malignant glioma	8.96e-06	0.000115	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CB—malignant glioma	8.56e-06	0.00011	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTGS2—malignant glioma	8.49e-06	0.000109	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PTEN—malignant glioma	8.29e-06	0.000106	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CB—malignant glioma	7.81e-06	9.99e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTGS2—malignant glioma	7.74e-06	9.9e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PTEN—malignant glioma	7.4e-06	9.47e-05	CbGpPWpGaD
Torasemide—PTGS1—Metabolism—AKT1—malignant glioma	7.4e-06	9.47e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PTEN—malignant glioma	6.75e-06	8.64e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—PIK3CA—malignant glioma	5.85e-06	7.48e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—PIK3CA—malignant glioma	5.22e-06	6.68e-05	CbGpPWpGaD
Torasemide—CYP2C8—Metabolism—AKT1—malignant glioma	4.78e-06	6.11e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—PIK3CA—malignant glioma	4.76e-06	6.09e-05	CbGpPWpGaD
Torasemide—CYP2C19—Metabolism—AKT1—malignant glioma	4.27e-06	5.46e-05	CbGpPWpGaD
Torasemide—CYP2C9—Metabolism—AKT1—malignant glioma	3.89e-06	4.98e-05	CbGpPWpGaD
